Home › Myelofibrosis › Illinois › Chicago
Myelofibrosis clinical trials in Chicago, IL
7 studies for Myelofibrosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- University of Chicago, Chicago
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- University of Chicago Medical Center, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecruitingPhase 1
- University of Chicago, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RecruitingObservational study
- MPN Research Foundation, Chicago
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
RecruitingPhase 1
- The University of Chicago, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Chicago
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Boston, MA12 studies
- Durham, NC12 studies
- Columbus, OH11 studies
- Seattle, WA11 studies
- Miami, FL10 studies
- Salt Lake City, UT10 studies
- Atlanta, GA9 studies
- Tampa, FL9 studies
- Nashville, TN9 studies
- Cleveland, OH9 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.